미리 감사드립니다.
ㅠㅠ
[Conclusion]
EGC, without LN exceeding 8 mm.
[Finding]
CLINICAL INFORMATION: Stomach cancer preoperative (pre-ESD) staging.
COMPARISON:
FINDINGS:
<This report form applies to patients suspected (or confirmed) to have stomach cancer without obvious metastasis in the previous work up.>
1. M staging.
1-1. Retroperitoneal LN (-/equivocal/+): -
1-2. Hepatic metastasis (-/equivocal/+): -
1-3. Peritoneal metastasis (-/equivocal/+): -
1-4. Other site:
2. N staging
2-1. The number of LN exceeding 8 mm in short diameter in transverse plane is: 0
2-2. LN stations (from #1 to #12) containing any measurable LN (>= 3 mm in short axis in transverse plane) are as follows.
Station #, with the largest LN measuring X mm in short diameter in transverse plane.
3. T staging (no visualization, T1, T2, T3, T4a, T4b): T1/T2
3-1. Macroscopic type
3-1-1. In case of EGC, (polypoid, mural): mural
3-1-2. In case of AGC, (Borrmann type I, II, III, IV):
3-2. Location (upper, middle, lower): lower
3-2-1. Involvement of the EG junction: (-/equivocal/+): -
3-2-2. Extension to the esophagus: (-/equivocal/+): -
3-2-3. Involvement of the pylorus: (-/equivocal/+): -
3-2-4. Extension to the duodenum: (-/equivocal/+): -
3-3. Involved organ in case of T4b (T-mesocolon, pancreas, liver): -
3-4. Gastric outlet obstruction (-/equivocal/+): -
4. Arterial anatomy variation: -
5. Incidental findings:
This report form was last modified on November 4, 2020, according to AJCC 8th edition.